512
Interference of A-v Integrins Blocks HIV-1 Infection in Macrophages
B Bosch1, I Clotet-Codina1, J Blanco1, G Comma1, S Cedeño1, F Mitjans2, J Piulats2, M Bofill1, B Clotet1, and Jose A. Este*1
1Fndn irsiCaixa, Badalona, Spain and 2Merck Farma y Química, Barcelona, Spain
Background: Macrophages are key cells for HIV infection
and spreading inside the organism. Macrophages cultured in vitro can be
successfully infected after differentiation with cytokines, such as macrophage
colony stimulating factor (M-CSF). In the monocyte to
macrophage differentiation process with M-CSF, an up-regulation of av-integrins is produced concomitantly to the HIV capacity to
replicate in monocyte-derived macrophages. We have
evaluated the role of av-integrins in the replication of HIV-1 in macrophages.
Methods: Primary monocytes
from healthy donors were used to generate M-CSF-derived macrophages (MDM). HIV
receptor and co-receptor expression and av-integrin
expression were measured by flow cytometry. HIV
replication in acutely and chronic MDM as measured by p24 antigen production
and HIV entry by qPCR analysis were used to evaluated
the effect of av-integrin
ligands in HIV infection.
Results: We show
that an anti-av
antibody, 17E6, inhibited HIV-1 infection of primary macrophages. The effect of
17E6 on HIV-1BaL replication
in acutely infected macrophages was dose-dependent, with a 50% effective
concentration (EC50) of 17±2 μg/mL
and without cytotoxic effects. Similarly, an anti-avb6
antibody, 14D9.F8, inhibited HIV-1BaL
replication in MDM; 17E6 reduced synthesis of HIV-1BaL proviral DNA in acutely infected macrophages as long as 18
hours post-infection, but was completely ineffective against HIV-1BaL production in chronically infected macrophages,
suggesting that this antibody inhibited HIV infection at an early stage of the
virus cycle. Consistently, preincubation of
differentiating monocytes with 17E6 decreased cell
surface density of CD4, CCR5, and CD14 about 20, 40, and 50%, respectively. Conversely
to av-integrin agonists vitronectin and fibronectin, 17E6
did not induce the production of chemokines (CCL3,
CCL4, or CCL5) affecting HIV infection. A small molecular weight antagonist of av-containing
integrins effectively blocked HIV replication in MDM
but not in lymphoid CD4+ cells.
Conclusions: Our results provide evidence for a role of av-containing
integrins in HIV replication in macrophages, and
suggest that small molecular weight compounds may be developed to interfere
with HIV replication in macrophages through interaction with av-integrins.
|